Generics

The Hemabate brand had a market value of approximately $55 million for the most recent 12 months ended April 2019, according to IQVIA.

Dantrolene capsules 25 mg, 50 mg and 100 mg had a market value of approximately $6.4 million for the 12 months ended April 2019, although actual generic market values are expected to be lower.

FDC's dorzolamide and timolol ophthalmic solution is a generic of Oak Pharmaceutical's Cosopt.

Teva's generic Diclegis is used to treat nausea and vomiting during pregnancy in women who have not improved with change in diet or other non-medicine treatments.

Camber received HDA's award for Second Merit Finalist for Best Overall Generic Pharmaceutical Product Manufacturer with Less Than $100 Million in Sales to Healthcare Distributors.

Oseltamivir phosphate capsules have a market value of $647 million for the 12 months ending December 2018, according to IQVIA.

Fresenius Kabi is offering dexmedetomidine hydrochloride in a ready-to-use formulation.

Bromfenac ophthalmic solution 0.09% has a market value of $6 million for the 12 months ending December 2018, according to IQVIA.